Defensive Stocks Strategy
The list refreshes about once a day.
This sleeve emphasizes lower-beta candidates with defensive business profiles, durable quality signals, and income support across healthcare, consumer staples, insurance, and financial services.
Rebalance history
| Date | Holdings | Added | Removed | Strategy % | S&P % |
|---|---|---|---|---|---|
| 2026-10-31 | 7 of 7 | ABBV EOG CINF KO CME REGN ALL | — | 0.0% | — |
| 2026-11-02 | 7 of 7 | RNR V ECO ELC | EOG CINF CME REGN | 0.0% | — |
| 2026-11-03 | 6 of 6 | JNJ FMX | ABBV ECO ELC | +1.8% | — |
| 2026-11-04 | 7 of 7 | MA BRK-B AZN | JNJ FMX | +3.8% | — |
| 2026-11-05 | 7 of 7 | DSGX FMX | V MA | +3.5% | — |
| 2026-11-06 | 6 of 6 | PG ABBV V | BRK-B DSGX FMX ALL | +3.5% | — |
| 2026-11-07 | 6 of 6 | DSGX | AZN | +3.1% | — |
| 2026-11-08 | 7 of 7 | JNJ BRK-B AZN | ABBV V | +3.1% | — |
| 2026-11-09 | 6 of 6 | ABBV ALL | BRK-B AZN DSGX | +4.3% | — |
| 2026-11-10 | 7 of 7 | BRK-B AZN GIB | ABBV ALL | +5.1% | — |
| 2026-11-11 | 7 of 7 | ABBV V MA | JNJ BRK-B GIB | +4.3% | — |
| 2026-11-12 | 6 of 6 | DSGX FNV | V MA AZN | +5.1% | — |
| 2026-11-13 | 7 of 7 | ALL GIB V CVX | PG DSGX FNV | +5.6% | — |
| 2026-11-14 | 6 of 6 | PG | GIB CVX | +5.6% | — |
| 2026-11-15 | 6 of 6 | JNJ | ABBV | +5.6% | — |
| 2026-11-16 | 6 of 6 | ABBV | JNJ | +6.5% | — |
| 2026-11-17 | 7 of 7 | AZN | — | +6.0% | — |
Current holdings
- AbbVie Inc. (ABBV) 18.0% weight $292.16
- The Allstate Corporation (ALL) 16.0% weight $271.30
- The Coca-Cola Company (KO) 15.0% weight $99.34
- The Procter & Gamble Company (PG) 14.0% weight $172.56
- RenaissanceRe Holdings Ltd. (RNR) 14.0% weight $355.56
- Visa Inc. (V) 12.0% weight $424.93
- AstraZeneca PLC (AZN) 11.0% weight $181.75
This is not financial advice. Portfolios and picks are generated by an AI model from market data for information only. Weights, AI ratings, and confidence are model output, not a recommendation to buy or sell any security.